PTC Therapeutics, Inc. short interest in 2023
In 2023, PTC Therapeutics, Inc.'s disclosed short interest ran from 6.59% of shares outstanding on 13 Jan 2023 to 12.96% on 29 Dec 2023, a change of +6.37 percentage points. The year's high was 12.96% on 29 Dec 2023 and its low 6.59% on 13 Jan 2023, averaging 9.18% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.56 days on 31 Aug 2023. Full history: PTC Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 6.59% (13 Jan 2023)
- End of year
- 12.96% (29 Dec 2023)
- Change
- +6.37 pp
- High
- 12.96% (29 Dec 2023)
- Low
- 6.59% (13 Jan 2023)
- Average
- 9.18%
- Highest days to cover
- 19.56 (31 Aug 2023)
- SEC filings marked
- 9
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 6.59% | 4.86 | results (8-K) |
| 31 Jan 2023 | 8.07% | 7.46 | |
| 15 Feb 2023 | 6.93% | 10.93 | |
| 28 Feb 2023 | 6.95% | 7.16 | 10-K filed, results (8-K) |
| 15 Mar 2023 | 7.58% | 6.72 | |
| 31 Mar 2023 | 7.48% | 6.66 | |
| 14 Apr 2023 | 7.29% | 8.91 | |
| 28 Apr 2023 | 7.03% | 6.11 | 10-Q filed, results (8-K) |
| 15 May 2023 | 7.31% | 7.15 | |
| 31 May 2023 | 8.55% | 4.60 | |
| 15 Jun 2023 | 10.12% | 11.74 | |
| 30 Jun 2023 | 10.39% | 8.01 | |
| 14 Jul 2023 | 10.05% | 13.54 | |
| 31 Jul 2023 | 9.50% | 8.61 | |
| 15 Aug 2023 | 9.57% | 13.31 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 9.82% | 19.56 | |
| 15 Sep 2023 | 9.79% | 5.24 | |
| 29 Sep 2023 | 10.63% | 4.81 | |
| 13 Oct 2023 | 9.32% | 4.18 | |
| 31 Oct 2023 | 9.78% | 3.85 | 10-Q filed, results (8-K) |
| 15 Nov 2023 | 10.71% | 6.30 | |
| 30 Nov 2023 | 11.78% | 10.44 | |
| 15 Dec 2023 | 12.22% | 7.28 | |
| 29 Dec 2023 | 12.96% | 9.57 |
See also: PTC Therapeutics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.